AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
sales of 14.84 billion Euro [US$16.65 billion]
of which 42%
Novo Nordisk As
(111.83 billion Danish Kroner [US$16.81 billion]
of which 84%
was Diabetes and obesity), and
Lonza Group AG
based in Switzerland
(5.54 billion Swiss Francs [US$5.61 billion]
of which 56%
During the year ended December of 2018, sales at
AstraZeneca PLC were £16.60 billion (US$20.65 billion).
decrease of 3.8%
versus 2017, when the company's sales were £17.25 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, AstraZeneca PLC had sales
of £16.41 billion.